Cell Source, Inc. (19) | Uncategorized (3)
- AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT (Filed With SEC on May 20, 2019)
- ยง 1 Subject matter (Filed With SEC on April 1, 2019)
- SPONSORED RESEARCH AGREEMENT (Filed With SEC on April 1, 2019)
